DST-funded start-ups develops electrochemical ELISA test for Covid antibody concentration
While qualitative analysis detects constituent elements in the sample, semi-quantitative analysis gives an approximate estimation of their concentrations.
Share Via Email
| A+A A-
By PTI
NEW DELHI: A Bengaluru-based start-up has developed a novel, point-of-care electrochemical ELISA test that enables fast and accurate estimation of total antibody concentration of COVID-19 in clinical samples, the Department of Science and Technology (DST) said on Saturday.
PathShodh Healthcare, the start-up incubated at the Society for Innovation and Development (SID), Indian Institute of Science (IISc), has made a very significant breakthrough to develop the first-of-its-kind, semi-quantitative electrochemical ELISA test for COVID-19 IgM and IgG antibodies.